No menu items!

Covid-19: South Korean drug to reach Brazil this Friday

RIO DE JANEIRO, BRAZIL - The drug Regkirona (regdanvimabe), which aims to treat early cases of Covid-19, will reach Brazil on Friday, September 3. The product was approved for emergency use by the Brazilian Health Regulatory Agency (ANVISA) on August 11 and should have its use restricted to hospitals - public and private.

Regdanvimab is a monoclonal antibody, that is, it is a product produced in a laboratory that reproduces the body's defenses capable of helping to fight a specific disease.

The company points out that the drug will not be sold in pharmacies, does not work as an early . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content